Hemispherx Biopharma Avian Flu Prevention/Treatment Program Announces New Primate Results And Expands In Both Europe And Southern Hemisphere

Published: Feb 14, 2007

PHILADELPHIA--(BUSINESS WIRE)--Hemispherx Biopharma, Inc. (AMEX:HEB) announced today initial results of a new primate treatment program with Viroclinics, based in the Netherlands, and directed by Professor Albert Osterhaus, a world authority in Avian influenza spread and prevention.

Back to news